Foamy virus--adenovirus hybrid vectors. 2004

M Picard-Maureau, and F Kreppel, and D Lindemann, and T Juretzek, and O Herchenröder, and A Rethwilm, and S Kochanek, and M Heinkelein
Institut für Virologie und Immunbiologie, Universität Würzburg, Germany.

To confer adenovirus vectors (AdV), the feature of integration into the host cell genome hybrid vectors were characterized in vitro, which express vectors derived from the prototypic foamy virus (FV) in the backbone of a high-capacity AdV. FVs constitute a subfamily of retroviruses with a distinct replication pathway and no known pathogenicity. In the absence of envelope glycoprotein, the prototypic FV behaves like a retrotransposon, while it behaves like an exogenous retrovirus in its presence. Two principle types of vectors, which either allows the intracellular (HC-FAD-7) or, in addition, the extracellular (HC-FAD-2) pathway were constructed. In both chimeras the expression of the FV vector was controlled by the tetracycline-regulatable system. Hybrids were produced close to 10(10) infectious units/ml. By Southern blotting, the functionality of the hybrid vectors to generate host cell genomic integrants was shown. However, the efficiency of HC-FAD-7 to establish stable transgene expression was rather low, while around 70% of cells were stably transduced in secondary round following primary transduction with HC-FAD-2 at an MOI of 100. Given the benign characteristics of high-capacity adenovirus and FV vectors, hybrids based on HC-FAD-2 are probably suited for an in vivo application.

UI MeSH Term Description Entries
D008164 Luminescent Proteins Proteins which are involved in the phenomenon of light emission in living systems. Included are the "enzymatic" and "non-enzymatic" types of system with or without the presence of oxygen or co-factors. Bioluminescent Protein,Bioluminescent Proteins,Luminescent Protein,Photoprotein,Photoproteins,Protein, Bioluminescent,Protein, Luminescent,Proteins, Bioluminescent,Proteins, Luminescent
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002678 Chimera An individual that contains cell populations derived from different zygotes. Hybrids,Chimeras,Hybrid
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000256 Adenoviridae A family of non-enveloped viruses infecting mammals (MASTADENOVIRUS) and birds (AVIADENOVIRUS) or both (ATADENOVIRUS). Infections may be asymptomatic or result in a variety of diseases. Adenoviruses,Ichtadenovirus,Adenovirus,Ichtadenoviruses
D013754 Tetracyclines Closely congeneric derivatives of the polycyclic naphthacenecarboxamide. (Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1117)
D014161 Transduction, Genetic The transfer of bacterial DNA by phages from an infected bacterium to another bacterium. This also refers to the transfer of genes into eukaryotic cells by viruses. This naturally occurring process is routinely employed as a GENE TRANSFER TECHNIQUE. Genetic Transduction,Genetic Transductions,Transductions, Genetic
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications

Related Publications

M Picard-Maureau, and F Kreppel, and D Lindemann, and T Juretzek, and O Herchenröder, and A Rethwilm, and S Kochanek, and M Heinkelein
January 2013, The journal of gene medicine,
M Picard-Maureau, and F Kreppel, and D Lindemann, and T Juretzek, and O Herchenröder, and A Rethwilm, and S Kochanek, and M Heinkelein
February 2004, Gene therapy,
M Picard-Maureau, and F Kreppel, and D Lindemann, and T Juretzek, and O Herchenröder, and A Rethwilm, and S Kochanek, and M Heinkelein
January 2003, Current topics in microbiology and immunology,
M Picard-Maureau, and F Kreppel, and D Lindemann, and T Juretzek, and O Herchenröder, and A Rethwilm, and S Kochanek, and M Heinkelein
January 1996, Journal of virology,
M Picard-Maureau, and F Kreppel, and D Lindemann, and T Juretzek, and O Herchenröder, and A Rethwilm, and S Kochanek, and M Heinkelein
September 2010, Journal of virology,
M Picard-Maureau, and F Kreppel, and D Lindemann, and T Juretzek, and O Herchenröder, and A Rethwilm, and S Kochanek, and M Heinkelein
November 1998, Human gene therapy,
M Picard-Maureau, and F Kreppel, and D Lindemann, and T Juretzek, and O Herchenröder, and A Rethwilm, and S Kochanek, and M Heinkelein
January 2003, Methods in molecular medicine,
M Picard-Maureau, and F Kreppel, and D Lindemann, and T Juretzek, and O Herchenröder, and A Rethwilm, and S Kochanek, and M Heinkelein
April 2008, Molecular therapy : the journal of the American Society of Gene Therapy,
M Picard-Maureau, and F Kreppel, and D Lindemann, and T Juretzek, and O Herchenröder, and A Rethwilm, and S Kochanek, and M Heinkelein
January 2002, Methods in enzymology,
M Picard-Maureau, and F Kreppel, and D Lindemann, and T Juretzek, and O Herchenröder, and A Rethwilm, and S Kochanek, and M Heinkelein
November 2009, Expert opinion on biological therapy,
Copied contents to your clipboard!